drugset / Trial / NCT00660348

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

NCT00660348 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

RATIONALE: Giving medications in different ways may change their effectiveness in controlling pain. It is not yet known whether intrathecal therapy is more effective than standard therapy in controlling pain in patients with pancreatic cancer. PURPOSE: This randomized clinical trial is studying standard pain control to see how well it works compared with intrathecal therapy in controlling pain in patients with locally advanced, unresectable, or metastatic pancreatic cancer.

Timeline

Start
2008-03
Primary completion
2011-03
Completion
2011-03

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified — Intravenous